TMEM181
geneOn this page
Summary
TMEM181 (transmembrane protein 181, HGNC:20958) is a protein-coding gene on chromosome 6q25.3, encoding Transmembrane protein 181 (Q9P2C4). Mediates action of cytolethal distending toxins (CDT), which are secreted by many pathogenic bacteria.
The TMEM181 gene encodes a putative G protein-coupled receptor expressed on the cell surface (Carette et al., 2009 [PubMed 19965467]; Wollscheid et al., 2009 [PubMed 19349973]).
Source: NCBI Gene 57583 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 110 total
- MANE Select transcript:
NM_001376852
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20958 |
| Approved symbol | TMEM181 |
| Name | transmembrane protein 181 |
| Location | 6q25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000146433 |
| Ensembl biotype | protein_coding |
| OMIM | 613209 |
| Entrez | 57583 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 11 nonsense_mediated_decay, 6 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000367090, ENST00000684151, ENST00000714113, ENST00000714114, ENST00000714115, ENST00000714116, ENST00000714117, ENST00000714118, ENST00000714119, ENST00000714120, ENST00000714121, ENST00000714122, ENST00000714124, ENST00000714125, ENST00000714194, ENST00000714203, ENST00000714212, ENST00000714225, ENST00000714226, ENST00000714227
RefSeq mRNA: 7 — MANE Select: NM_001376852
NM_001376817, NM_001376850, NM_001376852, NM_001376854, NM_001376855, NM_001376856, NM_020823
CCDS: CCDS43520, CCDS94026
Canonical transcript exons
ENST00000684151 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000975838 | 158573420 | 158573523 |
| ENSE00000975839 | 158580940 | 158580995 |
| ENSE00000975840 | 158583954 | 158584044 |
| ENSE00000975841 | 158585304 | 158585425 |
| ENSE00000975842 | 158589672 | 158589782 |
| ENSE00000975843 | 158605267 | 158605347 |
| ENSE00000975844 | 158607244 | 158607343 |
| ENSE00000975845 | 158608333 | 158608463 |
| ENSE00000975846 | 158608659 | 158608750 |
| ENSE00000975847 | 158623550 | 158623607 |
| ENSE00000975848 | 158625104 | 158625206 |
| ENSE00000975849 | 158625703 | 158625754 |
| ENSE00000975852 | 158631323 | 158631389 |
| ENSE00001443461 | 158629730 | 158629819 |
| ENSE00001443462 | 158628408 | 158628490 |
| ENSE00003920921 | 158560091 | 158560232 |
| ENSE00004023154 | 158631810 | 158635429 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 98.11.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 36.6387 / max 398.7661, expressed in 1819 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 70840 | 32.1521 | 1819 |
| 70841 | 3.3418 | 1482 |
| 70838 | 0.8540 | 258 |
| 70839 | 0.1667 | 94 |
| 70837 | 0.1241 | 47 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pylorus | UBERON:0001166 | 98.11 | gold quality |
| cardia of stomach | UBERON:0001162 | 97.74 | gold quality |
| saphenous vein | UBERON:0007318 | 97.43 | gold quality |
| pericardium | UBERON:0002407 | 97.31 | gold quality |
| ileal mucosa | UBERON:0000331 | 96.99 | gold quality |
| tibial artery | UBERON:0007610 | 96.89 | gold quality |
| popliteal artery | UBERON:0002250 | 96.88 | gold quality |
| superior surface of tongue | UBERON:0007371 | 96.25 | gold quality |
| trachea | UBERON:0003126 | 96.05 | gold quality |
| medulla oblongata | UBERON:0001896 | 95.96 | gold quality |
| mammary duct | UBERON:0001765 | 95.85 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 95.65 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 95.55 | gold quality |
| jejunal mucosa | UBERON:0000399 | 95.31 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 95.19 | gold quality |
| urethra | UBERON:0000057 | 94.97 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 94.71 | gold quality |
| tongue | UBERON:0001723 | 94.57 | gold quality |
| cauda epididymis | UBERON:0004360 | 94.49 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 94.48 | gold quality |
| pons | UBERON:0000988 | 94.47 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 94.34 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 94.34 | gold quality |
| colonic mucosa | UBERON:0000317 | 94.14 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 94.06 | gold quality |
| upper arm skin | UBERON:0004263 | 93.87 | gold quality |
| vena cava | UBERON:0004087 | 93.59 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 93.58 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 93.53 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 93.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.46 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
151 targeting TMEM181, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem181 | ENSDARG00000045910 |
| mus_musculus | Tmem181a | ENSMUSG00000038141 |
| rattus_norvegicus | Tmem181 | ENSRNOG00000018158 |
| drosophila_melanogaster | CG13409 | FBGN0038926 |
Protein
Protein identifiers
Transmembrane protein 181 — Q9P2C4 (reviewed: Q9P2C4)
All UniProt accessions (12): Q9P2C4, A0AAQ5BHF0, A0AAQ5BHG2, A0AAQ5BHJ8, A0AAQ5BHK1, A0AAQ5BHK4, A0AAQ5BHL1, A0AAQ5BHL6, A0AAQ5BHM7, A0AAQ5BHM8, A0AAQ5BHQ5, A0AAQ5BHT8
UniProt curated annotations — full annotation on UniProt →
Function. Mediates action of cytolethal distending toxins (CDT), which are secreted by many pathogenic bacteria. Expression level of TMEM181 is rate-limiting for intoxication.
Subunit / interactions. Interacts with cytolethal distending toxin.
Subcellular location. Membrane.
Similarity. Belongs to the TMEM181 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9P2C4-2 | 2 | yes |
| Q9P2C4-1 | 1 |
RefSeq proteins (7): NP_001363746, NP_001363779, NP_001363781, NP_001363783, NP_001363784, NP_001363785, NP_065874 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR040416 | TMEM181 | Family |
| IPR047843 | WLS-like_TM | Domain |
| IPR054077 | TMEM181_GOLD | Domain |
Pfam: PF06664, PF21885
UniProt features (12 total): transmembrane region 9, chain 1, modified residue 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P2C4-F1 | 78.28 | 0.23 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 443
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
chr6q25, GOMF_TOXIC_SUBSTANCE_BINDING, MEISSNER_NPC_HCP_WITH_H3K27ME3, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3, MIKKELSEN_MEF_HCP_WITH_H3K27ME3, SERVITJA_LIVER_HNF1A_TARGETS_UP, WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP, LIM_MAMMARY_STEM_CELL_DN, E2F5_TARGET_GENES, HMG20B_TARGET_GENES, KLF7_TARGET_GENES, MIER1_TARGET_GENES, PHF21A_TARGET_GENES, ZNF197_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): toxic substance binding (GO:0015643)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1236 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM181 | SGMS1 | Q86VZ5 | 574 |
| TMEM181 | TULP4 | Q9NRJ4 | 481 |
| TMEM181 | VN1R1 | Q9GZP7 | 423 |
| TMEM181 | ALOXE3 | Q9BYJ1 | 407 |
| TMEM181 | LSR | Q86X29 | 401 |
| TMEM181 | TOE1 | Q96GM8 | 400 |
| TMEM181 | ALDH18A1 | P54886 | 393 |
| TMEM181 | GPR107 | Q5VW38 | 376 |
| TMEM181 | OR10A6 | Q8NH74 | 375 |
| TMEM181 | GPRC5C | Q9NQ84 | 374 |
| TMEM181 | SYNGR2 | O43760 | 368 |
| TMEM181 | ERAP2 | Q6P179 | 368 |
| TMEM181 | DYNLT1 | P63172 | 366 |
| TMEM181 | TAGAP | Q8N103 | 365 |
| TMEM181 | TMEM165 | Q9HC07 | 359 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SCN3B | ABCC5 | psi-mi:“MI:0914”(association) | 0.530 |
| DPEP1 | ILVBL | psi-mi:“MI:0914”(association) | 0.530 |
| SLC39A4 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| LPAR1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| ESYT2 | psi-mi:“MI:0914”(association) | 0.350 | |
| DPEP1 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| NPC1 | psi-mi:“MI:0914”(association) | 0.350 | |
| KLRC3 | RNF13 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPAN15 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| ENTPD7 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| SCN3B | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| SPPL2B | HAS3 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPAN3 | SCAMP3 | psi-mi:“MI:0914”(association) | 0.350 |
| FPR2 | SCAMP3 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPAN17 | MGST3 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPAN18 | ITGA6 | psi-mi:“MI:0914”(association) | 0.350 |
| SCN3B | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| VSIG4 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC25A37 | RAB30 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC12A9 | PGRMC1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC19A2 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC39A7 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (30): TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-RNA), TMEM181 (Affinity Capture-RNA), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS), TMEM181 (Affinity Capture-MS)
ESM2 similar proteins: A0JNC1, A0PK00, A1L2R7, A2BIE7, A3KNK1, A6QPF8, A7XZ53, A8DZH4, D3ZEH5, O35052, O95427, P98191, Q05B45, Q0VFK3, Q17QL9, Q1LY80, Q28CY9, Q3TA38, Q5BL21, Q5EAX9, Q5EAY8, Q5FWV6, Q5HZE2, Q5RET6, Q5U239, Q5ZMP3, Q63ZG0, Q68EY2, Q6DD44, Q6DE21, Q6ZMG9, Q7ZUA6, Q8BXA5, Q8C172, Q8C1E7, Q8CIF6, Q8NBJ9, Q8WVP7, Q91XU8, Q92903
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
110 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 93 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3505 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:158536849:G:GT | donor_gain | 1.0000 |
| 6:158573414:CCCCA:C | acceptor_loss | 1.0000 |
| 6:158573415:CCCAG:C | acceptor_loss | 1.0000 |
| 6:158573416:CCAG:C | acceptor_loss | 1.0000 |
| 6:158573417:CA:C | acceptor_loss | 1.0000 |
| 6:158573418:A:AG | acceptor_gain | 1.0000 |
| 6:158573418:AGG:A | acceptor_loss | 1.0000 |
| 6:158573419:G:GG | acceptor_gain | 1.0000 |
| 6:158573521:GAG:G | donor_gain | 1.0000 |
| 6:158573522:AG:A | donor_loss | 1.0000 |
| 6:158573523:GG:G | donor_loss | 1.0000 |
| 6:158573524:G:GG | donor_gain | 1.0000 |
| 6:158585299:TGTA:T | acceptor_loss | 1.0000 |
| 6:158585300:GTA:G | acceptor_loss | 1.0000 |
| 6:158585301:TAGA:T | acceptor_loss | 1.0000 |
| 6:158585302:A:AC | acceptor_loss | 1.0000 |
| 6:158585302:A:AG | acceptor_gain | 1.0000 |
| 6:158585303:G:GG | acceptor_gain | 1.0000 |
| 6:158585303:GA:G | acceptor_gain | 1.0000 |
| 6:158585303:GAA:G | acceptor_gain | 1.0000 |
| 6:158585303:GAAA:G | acceptor_gain | 1.0000 |
| 6:158585423:GGG:G | donor_gain | 1.0000 |
| 6:158585424:GG:G | donor_gain | 1.0000 |
| 6:158585424:GGG:G | donor_gain | 1.0000 |
| 6:158585425:GG:G | donor_gain | 1.0000 |
| 6:158585426:G:GA | donor_loss | 1.0000 |
| 6:158585427:T:A | donor_loss | 1.0000 |
| 6:158585428:G:GG | donor_loss | 1.0000 |
| 6:158589671:GAAAT:G | acceptor_gain | 1.0000 |
| 6:158589778:TCACA:T | donor_gain | 1.0000 |
AlphaMissense
3117 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:158607263:T:C | L335P | 0.999 |
| 6:158607271:T:C | F338L | 0.999 |
| 6:158607273:T:A | F338L | 0.999 |
| 6:158607273:T:G | F338L | 0.999 |
| 6:158607286:T:A | W343R | 0.999 |
| 6:158607286:T:C | W343R | 0.999 |
| 6:158607288:G:C | W343C | 0.998 |
| 6:158607288:G:T | W343C | 0.998 |
| 6:158607304:T:A | W349R | 0.998 |
| 6:158607304:T:C | W349R | 0.998 |
| 6:158608431:T:A | W395R | 0.998 |
| 6:158608431:T:C | W395R | 0.998 |
| 6:158631356:T:C | M576T | 0.998 |
| 6:158629764:C:A | N546K | 0.997 |
| 6:158629764:C:G | N546K | 0.997 |
| 6:158631337:G:C | D570H | 0.997 |
| 6:158631357:G:A | M576I | 0.997 |
| 6:158631357:G:C | M576I | 0.997 |
| 6:158631357:G:T | M576I | 0.997 |
| 6:158607272:T:C | F338S | 0.996 |
| 6:158608680:T:C | F413L | 0.996 |
| 6:158608682:C:A | F413L | 0.996 |
| 6:158608682:C:G | F413L | 0.996 |
| 6:158631350:T:C | F574S | 0.996 |
| 6:158631356:T:A | M576K | 0.996 |
| 6:158631359:T:C | L577P | 0.996 |
| 6:158625709:G:T | R492M | 0.995 |
| 6:158629795:T:C | S557P | 0.995 |
| 6:158629799:C:A | P558Q | 0.995 |
| 6:158631350:T:G | F574C | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000044765 (6:158585151 C>A), RS1000082599 (6:158543029 C>A), RS1000091114 (6:158620564 C>T), RS1000096705 (6:158584905 T>A), RS1000123494 (6:158633198 CG>C), RS1000135376 (6:158630207 C>T), RS1000162384 (6:158574478 A>G), RS1000183166 (6:158536926 G>T), RS1000240742 (6:158614949 C>A,T), RS1000250598 (6:158535219 G>C,T), RS1000280386 (6:158545994 C>A,G,T), RS1000285244 (6:158609258 G>A,C), RS1000302886 (6:158535413 C>A,T), RS1000314645 (6:158614746 C>T), RS1000317657 (6:158568566 C>G,T)
Disease associations
OMIM: gene MIM:613209 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006065_10 | Glaucoma (primary open-angle) | 8.000000e-09 |
| GCST006412_61 | Intraocular pressure | 7.000000e-10 |
| GCST009725_89 | Intraocular pressure | 1.000000e-06 |
| GCST009726_11 | Glaucoma | 7.000000e-06 |
| GCST010396_55 | Gut microbiota (bacterial taxa, hurdle binary method) | 8.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004695 | intraocular pressure measurement |
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, increases abundance, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| Tretinoin | decreases expression, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| K 7174 | increases expression | 1 |
| abrine | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Coumestrol | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Thiram | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): glaucoma, open-angle glaucoma